KRAS and pancreatic intraductal papillary-mucinous neoplasm: A KRAS mutation (predominantly codon 12; occasionally codons 13 and 61) is an early event in IPMN tumorigenesis, but the presence of KRAS mutations does not correlate with the degree of dysplasia or histologic subtype of IPMNs [5].